氧化还原
适应(眼睛)
疾病
化学
钠
生物化学
细胞生物学
生产(经济)
新陈代谢
氧化还原
还原(数学)
生物
生物物理学
细胞适应
作者
Deqiang Zhang,Heling Chu,Yu Zhang,Ying Wang,Yan Zhang,Yaxin Guo,Peifeng Wan,Hangtian Yue,Guangqiang Sun,Yanjie Chao,Jing Zhang,Changrong Ge,Fang Xie,Zuoquan Xie,Qihao Guo,Meiyu Geng
出处
期刊:Gut
[BMJ]
日期:2026-10-23
卷期号:: gutjnl-2026
标识
DOI:10.1136/gutjnl-2026-339603
摘要
Background Sodium oligomannate (GV-971), a microbiome-centric therapy for Alzheimer’s disease (AD) in China, shows variable clinical efficacy. Objective To investigate the mechanisms underlying the differential responsiveness to GV-971 in AD therapy. Methods Cognitive/functional outcomes, Aβ-PET imaging, stool metagenomics and plasma metabolomics were assessed in AD patients. Post-treatment faecal microbiota were transplanted into 5xFAD mice, followed by behavioural, pathological and single-nucleus transcriptomic analyses. Indole-3-propionic acid (IPA) supplementation and colonisation with wild-type or IPA-deficient C. sporogenes (ΔfldC) were performed to evaluate the impact of IPA in vitro and in vivo. Redox potential measurement and bacterial transcriptional and metabolic profiling were performed to assess the redox status. Results AD patients treated with GV-971 were stratified into improved and non-improved cognitive responses based on changes in ADAS-Cog11 scores, accompanied by concordant changes in cerebral Aβ burden. Improved patients showed a more reductive gut state, characterised by reduced microbial respiratory electron-transport potential. Faecal microbiota transplantation from improved donors recapitulated the therapeutic benefits of GV-971 in 5xFAD mice. Targeted metabolomic analyses across humans and mice identified microbiota-derived IPA as a key mediator of GV-971’s therapeutic responses. IPA enhanced microglial Aβ uptake and lysosomal clearance via an AhR-dependent pathway. GV-971 treatment enriched IPA-producing bacteria of the genus Clostridium, particularly C. sporogenes. Colonisation with C. sporogenes elevated circulating IPA levels and concomitantly ameliorated cognitive deficits and AD-related pathology. Mechanistically, GV-971 lowered the culture redox potential and promoted IPA production by C. sporogenes. This gut redox status and associated IPA production were further recapitulated in complex microbial communities, as evidenced by GV-971-treated mice. Conclusion GV-971 ameliorates AD by remodelling microbial redox metabolism to boost bacterial IPA production, which enhances AhR-mediated microglial Aβ clearance and underpins its therapeutic efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI